🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an event driven Phase 3, prospective, randomized, open-label, blind...
Status
Completed
Location
Banner University Medical Center
Start Date
2017-03-27
Trial ID
NCT02798471
Treatments Being Tested
The main objective of this study is to demonstrate that a single anticoagul...
Status
Completed
Location
CHRU de Montpellier - Hôpital Arnaud de Villeneuve
Start Date
2017-06-01
Trial ID
NCT02735902
Treatments Being Tested
To assess whether edoxaban (60/30 mg daily) compared to non-antithrombotic ...
Status
Active Not Recruiting
Location
Alexian Brothers Medical Center
Start Date
2019-09-20
Trial ID
NCT03950076
Treatments Being Tested
This study will evaluate the establishment of anticoagulation ("re-anticoag...
Status
Completed
Location
Quintiles
Start Date
2014-03
Trial ID
NCT02207257
The investigators hypothesize that earlier initiation of edoxaban in AF-rel...
Status
Completed
Location
Asan Medical Center
Start Date
2018-06-19
Trial ID
NCT03433235
Treatments Being Tested
Study Design: Lixiana Acute Stroke Evaluation Registry (LASER) is a random...
Status
Completed
Location
University of Alberta
Start Date
2018-06-01
Trial ID
NCT03494530
Treatments Being Tested
The objective of this study is to assess the efficacy, safety and dose-resp...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT01203072
The goal of this clinical trial is to investigate pharmacokinetics and phar...
Status
Recruiting
Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Start Date
2024-01-18
Trial ID
NCT05869591
Treatments Being Tested
This is a multicentric, phase IV study. In this study patients that are rec...
Status
Completed
Location
Presidio Ospedaliero SS. Antonio e Biagio
Start Date
2019-06-27
Trial ID
NCT04072068
Treatments Being Tested
The primary objective is to demonstrate the non-inferiority of edoxaban (pr...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-16
Trial ID
NCT02073682
Treatments Being Tested